Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-28ANL3Alan Ming Lun Tse Form 3 - Initial Statement of Beneficial Ownership for Adlai Nortye Ltd.
This is a Form 3 filing by Alan Ming Lun Tse, a director of Adlai Nortye Ltd. (ticker: ANL), reporting his initial statement of beneficial ownership. The filing indicates that as of March 18, 2026, Tse owns no securities in the company. The document was signed on May 28, 2026, and shows Tse's position as a director but...
Small CapBiotechnology
2026-05-28APVO3Form 3 Filing for Mary Janatpour
This filing reports that Mary Janatpour, SVP, CSO of Aptevo Therapeutics Inc., has granted power of attorney to SoYoung Kwon and Daphne Taylor. This authorization allows the attorneys-in-fact to execute Forms 3, 4, and 5, and other necessary reports related to the ownership, acquisition, or disposition of the company's...
Nano CapBiotechnology
2026-05-28BNTC3Form 3 Filing for Benitec Biopharma Inc. - Ownership ChangeMEDIUM
This filing reports a change in beneficial ownership for David Matthew Friedman, a director at Benitec Biopharma Inc. (BNTC). The form, dated May 28, 2026, indicates that Mr. Friedman acquired securities on May 22, 2026. The filing specifies that Mr. Friedman is a director but not an officer or 10% owner. The number of...
Small CapBiotechnology
2026-05-28CAPR3Capricor Therapeutics Officer Michael T Maurer Power of Attorney Filing
This SEC Form 3 filing represents a power of attorney document for Michael T Maurer, Chief Commercial Officer of Capricor Therapeutics, Inc. The filing indicates that Linda Marban is authorized to act as attorney-in-fact for Maurer, with the signature dated May 28, 2026. The filing reports that Maurer owns no securitie...
Small CapBiotechnology